Compared to controls, LDL-C levels in CAD patients were significantly higher (2.71 ± 0.75 vs 3.04 ± 0.98 mmol/l, P = 0.009); whereas, HDL-C and ApoAI levels in patients were significantly lower than those in controls. This evidence concerns the gene APOA1 and coronary artery disorder.